Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suanzaoren for insomnia in adults with anxiety
ChiCTR1800019913Phase 4Completed
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zaoren anshen and alprazolam in Insomnia and anxiety disorder (2 arms), sponsored by Hangzhou Red Cross Hospital. Primary endpoint: Insomnia Severity Index. Started Feb 2018; status: completed.
02
Drugs
zaoren anshenalprazolam
03
Conditions
Insomniaanxiety disorder
Beyond the preview
Go deeper on ChiCTR1800019913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019913.